Table 2.
List of publications behind Figure 4 and impact of PMN-EVs on target cells.
| Group (Figure 4) | Effect | PMN-EV Induction Stimulus | Target | References | |
|---|---|---|---|---|---|
| A | No effect | apoptosis | PMN | [86] | |
| [89] | |||||
| Monocyte/macrophage | [87] | ||||
| [91] | |||||
| T-cell | [90] | ||||
| Anti-inflammatory | Monocyte/macrophage | [88] | |||
| Pro-coagulant | Coagulation | [86] | |||
| B | Anti-inflammatory | spontaneous release | Monocyte/macrophage | [85] | |
| PMN | [86] | ||||
| Pro-coagulant | Coagulation | [86] | |||
| C | 1 | Anti-inflammatory | fMLP | Monocyte/macrophage | [92] |
| [95] | |||||
| [93] | |||||
| [104] | |||||
| [94] | |||||
| C5a | [94] | ||||
| TNFα | [118] | ||||
| fMLP, IL-8 | NK | [96] | |||
| PAF | PMN | [97] | |||
| Pro-inflammatory | fMLP | Endothelium/HUVEC | [99] | ||
| [98] | |||||
| [100] | |||||
| [101] | |||||
| LPS | [114] | ||||
| TNFα | [137] | ||||
| TNFa, GM-CSF, IFN-γ | [102] | ||||
| fMLP + GM-CSF | PMN | [112] | |||
| C5a | [121] | ||||
| fMLP+LPS | Phagocytes | [113] | |||
| Pro-coagulant | fMLP | Coagulation | [98] | ||
| TNFα + ANCA | [137] | ||||
| LPS | [117] | ||||
| [116] | |||||
| 2 | Anti-inflammatory | fMLP | Monocyte/macrophage | [97] | |
| Pro-inflammatory | Phagocytes | [106] | |||
| Endothelium/HUVEC | [104] | ||||
| [103] | |||||
| 3 | Pro-inflammatory | fMLP | Endothelium/HUVEC | [108] | |
| [111] | |||||
| [102] | |||||
| 4 | Pro-inflammatory | ops. zymosan | PMN | [86] | |
| Bacteria | [149] | ||||
| ops. bacteria | Bacteria | [124] | |||
| ops. fungi | Fungi | [122] | |||
| M. tuberculosis | Monocyte/macrophage | [105] | |||
| Anti-inflammatory | [85] | ||||